EAACI Congress 2024
BackFT 07 - Flash talks on Drug Allergy 2
Friday 31 May, 16:45 PM -
18:15 PM Valencia, Spain
Palma
Flash Talks
16:45
Safety of direct and single-dose drug provocation test in low-risk penicillin allergy labels
16:52
Challenging the Norm: Rethinking the relevance of Cefixime challenges in confirmed penicillin-allergic patients
16:59
Ten-year Survival in Children with Acute Lymphoblastic Leukemia: The Impact of L-asparaginase Hypersensitivity and Desensitization
17:06
Predictive factors of breakthrough reactions during desensitization for oncological treatments
17:13
Hereditary α-tryptasemia is associated with increased risk for drug-induced anaphylaxis
17:20
The role of skin testing, serum IgE, and extended oral challenges in diagnosing childhood beta-lactam allergy: The CHildren Antibiotic Delabeling (CHAD) study
17:27
Food dependent NSAID-induced hypersensitivity - is there a link to specific components?
17:34
Beta-Lactam Antibiotic Stewardship Tool (BLAST): from CE-certification to integration in electronic health record systems in the Netherlands
17:41
Identifying the most at-risk age-group and longitudinal trends of drug allergy labelling among 7.3 million individuals in Hong Kong
17:48
An eleven-year experience with drug desensitization at a fourth level center in Colombia
17:55
Adverse drug reactions to taxanes: positive skin testing correlates with breakthrough reactions during drug desensitisation
18:02
The epidemiology of penicillin allergy labels in a Swedish healthcare region
